| NCJ Number: |
252921  |
| |
|
| Title: |
Chasing the Electronic Cigarette Dragon - Characterizing the Evolution and Impact of Design and Content |
| |
|
| Document: |
PDF |
| |
|
| Author(s): |
Michelle Peace; Justin L. Poklis; Joseph Turner |
| |
|
| Date Published: |
May 2019 |
| |
|
| Annotation: |
The reported research was designed to add to information on the nature of drug use, abuse, and overdose cases in which electronic cigarettes (e-cigs) were used to deliver an illicit drug.
|
| |
|
| Abstract: |
Current and previous research findings by this research team are included in this report to address 1) the characteristics of new models of electronic cigarettes and popular customizations; 2) the characteristics of e-liquids purchased over the counter or the internet; and 3) development of a model for the characterization of the particle-size distribution in aerosols. The project determined that fourth-generation e-cig products have evolved to facilitate the aerosolization of drugs from products that are not liquid, but are designed for waxes, dabs, and solid plant materials. E-liquids, semi-solids, and solid materials used in e-cigs can contain dangerous DOTNs, such as synthetic cannabinoids. Evidence indicates that any drug that can be made liquid is being used in e-cigs, including natural products considered “legal highs.” The majority of the particles’ distribution for nicotine was 0.172-1.0 mm, correlating with deposition in the pulmonary region. Mean particle size of a nicotine aerosol was 0.3 mm, similar to traditional cigarettes. No statistical difference of MMAD and particle-size distribution was found between different common voltages and coil resistances. Methamphetamine and methadone e-liquids generated similar particle-size distribution to nicotine. Methodologies used to obtain these findings are described. 12 figures, 1 table, and a listing of project-related scientific papers, invited talks, and media engagements
|
| |
|
| Main Term(s): |
Drug use |
| |
|
| Index Term(s): |
Drug abuse; Drug paraphernalia; Drug use; National Institute of Justice (NIJ); NIJ final report |
| |
|
| Grant Number: |
2016-DN-BX-0150 |
| |
|
| Sponsoring Agency: |
National Institute of Justice (NIJ)
Washington, DC 20531
US Dept of Justice NIJ Pub
Washington, DC 20531
Virginia Commonwealth University
Richmond, VA 23211 |
| |
|
| Corporate Author: |
Virginia Commonwealth University
United States of America |
| |
|
| Sale Source: |
US Dept of Justice NIJ Pub
810 Seventh Street, NW
Washington, DC 20531
United States of America |
| |
|
| Page Count: |
20 |
| |
|
| Format: |
Document; Document (Online) |
| |
|
| Type: |
Program/Project Description; Report (Grant Sponsored); Report (Study/Research); Research (Applied/Empirical) |
| |
|
| Language: |
English |
| |
|
| Country: |
United States of America |
| |
|
|
|
| |
|
|
To cite this abstract, use the following link:
http://www.ncjrs.gov/App/publications/abstract.aspx?ID=275149 |
| |
|
